Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PanGenomic Health, Inc. Class A ( (TSE:NARA) ) has issued an update.
PanGenomic Health Inc. has announced a repricing of 4,300,464 share purchase warrants from $0.50 to $0.17 per share, following unanimous consent from warrant holders. This change aims to potentially accelerate the expiration of warrants if the stock price reaches or exceeds $0.23 for ten consecutive trading days, enhancing liquidity and possibly attracting more stakeholders.
More about PanGenomic Health, Inc. Class A
PanGenomic Health Inc. is a precision health company focused on developing a self-care digital platform that provides personalized, evidence-based information on natural treatments, primarily supporting mental health. Based in British Columbia, the company’s mission is to enhance health and wellness through technology that identifies plant-based solutions tailored to individual health profiles.
YTD Price Performance: 83.33%
Average Trading Volume: 42,211
Technical Sentiment Consensus Rating: Hold
Current Market Cap: C$1.41M
For a thorough assessment of NARA stock, go to TipRanks’ Stock Analysis page.